nodes	percent_of_prediction	percent_of_DWPC	metapath
Diflunisal—PTGS2—bone cancer	0.754	1	CbGaD
Diflunisal—PTGS2—Cisplatin—bone cancer	0.0942	0.529	CbGbCtD
Diflunisal—SLC22A6—Methotrexate—bone cancer	0.0453	0.254	CbGbCtD
Diflunisal—ALB—Methotrexate—bone cancer	0.0386	0.217	CbGbCtD
Diflunisal—TTR—vertebral column—bone cancer	0.00287	0.286	CbGeAlD
Diflunisal—Allergic cutaneous angiitis—Methotrexate—bone cancer	0.00168	0.0328	CcSEcCtD
Diflunisal—Olsalazine—PTGS2—bone cancer	0.00137	0.222	CrCbGaD
Diflunisal—Aminosalicylic Acid—PTGS2—bone cancer	0.00128	0.208	CrCbGaD
Diflunisal—PTGS2—periosteum—bone cancer	0.0012	0.12	CbGeAlD
Diflunisal—Salsalate—PTGS2—bone cancer	0.00116	0.189	CrCbGaD
Diflunisal—Leukocytoclastic vasculitis—Methotrexate—bone cancer	0.00109	0.0213	CcSEcCtD
Diflunisal—Hearing impaired—Cisplatin—bone cancer	0.00103	0.02	CcSEcCtD
Diflunisal—Mesalazine—PTGS2—bone cancer	0.00101	0.164	CrCbGaD
Diflunisal—PTGS2—leg—bone cancer	0.00096	0.0957	CbGeAlD
Diflunisal—Body temperature increased—Carboplatin—bone cancer	0.000939	0.0183	CcSEcCtD
Diflunisal—PTGS2—hindlimb—bone cancer	0.000857	0.0855	CbGeAlD
Diflunisal—PTGS2—cartilage tissue—bone cancer	0.000844	0.0842	CbGeAlD
Diflunisal—Deafness—Cisplatin—bone cancer	0.000792	0.0154	CcSEcCtD
Diflunisal—Haemolytic anaemia—Cisplatin—bone cancer	0.000785	0.0153	CcSEcCtD
Diflunisal—PTGS2—appendage—bone cancer	0.000735	0.0734	CbGeAlD
Diflunisal—Salicylic acid—PTGS2—bone cancer	0.000714	0.116	CrCbGaD
Diflunisal—Gastrointestinal haemorrhage—Cisplatin—bone cancer	0.000709	0.0138	CcSEcCtD
Diflunisal—Cramp muscle—Cisplatin—bone cancer	0.000638	0.0124	CcSEcCtD
Diflunisal—Flurbiprofen—PTGS2—bone cancer	0.000626	0.102	CrCbGaD
Diflunisal—Proteinuria—Methotrexate—bone cancer	0.00061	0.0119	CcSEcCtD
Diflunisal—TTR—connective tissue—bone cancer	0.000604	0.0602	CbGeAlD
Diflunisal—Protein urine present—Methotrexate—bone cancer	0.000601	0.0117	CcSEcCtD
Diflunisal—Renal failure—Cisplatin—bone cancer	0.000537	0.0105	CcSEcCtD
Diflunisal—Stomatitis—Cisplatin—bone cancer	0.000532	0.0104	CcSEcCtD
Diflunisal—Eructation—Epirubicin—bone cancer	0.000493	0.00959	CcSEcCtD
Diflunisal—Visual impairment—Cisplatin—bone cancer	0.000472	0.0092	CcSEcCtD
Diflunisal—Tinnitus—Cisplatin—bone cancer	0.000457	0.0089	CcSEcCtD
Diflunisal—Eructation—Doxorubicin—bone cancer	0.000456	0.00887	CcSEcCtD
Diflunisal—Flushing—Cisplatin—bone cancer	0.000455	0.00886	CcSEcCtD
Diflunisal—Photosensitivity—Methotrexate—bone cancer	0.000443	0.00862	CcSEcCtD
Diflunisal—Flatulence—Cisplatin—bone cancer	0.000421	0.00819	CcSEcCtD
Diflunisal—Photosensitivity—Epirubicin—bone cancer	0.000414	0.00807	CcSEcCtD
Diflunisal—Dermatitis exfoliative—Methotrexate—bone cancer	0.000412	0.00802	CcSEcCtD
Diflunisal—Visual disturbance—Methotrexate—bone cancer	0.00041	0.00799	CcSEcCtD
Diflunisal—Muscle spasms—Cisplatin—bone cancer	0.00041	0.00799	CcSEcCtD
Diflunisal—Vision blurred—Cisplatin—bone cancer	0.000402	0.00783	CcSEcCtD
Diflunisal—TTR—bone marrow—bone cancer	0.000402	0.0401	CbGeAlD
Diflunisal—TTR—spinal cord—bone cancer	0.0004	0.0399	CbGeAlD
Diflunisal—Dermatitis exfoliative—Epirubicin—bone cancer	0.000386	0.00751	CcSEcCtD
Diflunisal—Photosensitivity—Doxorubicin—bone cancer	0.000383	0.00747	CcSEcCtD
Diflunisal—Renal impairment—Epirubicin—bone cancer	0.000382	0.00744	CcSEcCtD
Diflunisal—Gastrointestinal haemorrhage—Epirubicin—bone cancer	0.000364	0.00708	CcSEcCtD
Diflunisal—Dermatitis exfoliative—Doxorubicin—bone cancer	0.000357	0.00695	CcSEcCtD
Diflunisal—Renal impairment—Doxorubicin—bone cancer	0.000354	0.00689	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.00035	0.00682	CcSEcCtD
Diflunisal—Anaphylactic shock—Cisplatin—bone cancer	0.000348	0.00678	CcSEcCtD
Diflunisal—Oedema—Cisplatin—bone cancer	0.000348	0.00678	CcSEcCtD
Diflunisal—Thrombocytopenia—Cisplatin—bone cancer	0.000341	0.00664	CcSEcCtD
Diflunisal—Gastrointestinal haemorrhage—Doxorubicin—bone cancer	0.000337	0.00656	CcSEcCtD
Diflunisal—Hyperhidrosis—Cisplatin—bone cancer	0.000337	0.00656	CcSEcCtD
Diflunisal—Anorexia—Cisplatin—bone cancer	0.000332	0.00646	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.000328	0.00638	CcSEcCtD
Diflunisal—Gastritis—Epirubicin—bone cancer	0.000322	0.00627	CcSEcCtD
Diflunisal—Dysuria—Methotrexate—bone cancer	0.000314	0.00612	CcSEcCtD
Diflunisal—Paraesthesia—Cisplatin—bone cancer	0.000313	0.00609	CcSEcCtD
Diflunisal—Dyspnoea—Cisplatin—bone cancer	0.000311	0.00605	CcSEcCtD
Diflunisal—Photosensitivity reaction—Methotrexate—bone cancer	0.000307	0.00597	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000303	0.0059	CcSEcCtD
Diflunisal—Decreased appetite—Cisplatin—bone cancer	0.000303	0.00589	CcSEcCtD
Diflunisal—Gastritis—Doxorubicin—bone cancer	0.000298	0.0058	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000297	0.00578	CcSEcCtD
Diflunisal—Renal failure—Methotrexate—bone cancer	0.000295	0.00573	CcSEcCtD
Diflunisal—Dysuria—Epirubicin—bone cancer	0.000294	0.00573	CcSEcCtD
Diflunisal—Stomatitis—Methotrexate—bone cancer	0.000292	0.00569	CcSEcCtD
Diflunisal—Sweating—Methotrexate—bone cancer	0.000287	0.00559	CcSEcCtD
Diflunisal—Photosensitivity reaction—Epirubicin—bone cancer	0.000287	0.00559	CcSEcCtD
Diflunisal—Feeling abnormal—Cisplatin—bone cancer	0.000287	0.00559	CcSEcCtD
Diflunisal—Haematuria—Methotrexate—bone cancer	0.000286	0.00556	CcSEcCtD
Diflunisal—Agranulocytosis—Methotrexate—bone cancer	0.00028	0.00544	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000278	0.00541	CcSEcCtD
Diflunisal—Renal failure—Epirubicin—bone cancer	0.000276	0.00537	CcSEcCtD
Diflunisal—Body temperature increased—Cisplatin—bone cancer	0.000275	0.00536	CcSEcCtD
Diflunisal—Stomatitis—Epirubicin—bone cancer	0.000273	0.00532	CcSEcCtD
Diflunisal—Jaundice—Epirubicin—bone cancer	0.000273	0.00532	CcSEcCtD
Diflunisal—Dysuria—Doxorubicin—bone cancer	0.000272	0.0053	CcSEcCtD
Diflunisal—Hepatitis—Methotrexate—bone cancer	0.000269	0.00524	CcSEcCtD
Diflunisal—Sweating—Epirubicin—bone cancer	0.000269	0.00523	CcSEcCtD
Diflunisal—Haematuria—Epirubicin—bone cancer	0.000267	0.00521	CcSEcCtD
Diflunisal—Photosensitivity reaction—Doxorubicin—bone cancer	0.000266	0.00517	CcSEcCtD
Diflunisal—Agranulocytosis—Epirubicin—bone cancer	0.000262	0.0051	CcSEcCtD
Diflunisal—Visual impairment—Methotrexate—bone cancer	0.000259	0.00505	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000257	0.00501	CcSEcCtD
Diflunisal—Hypersensitivity—Cisplatin—bone cancer	0.000257	0.005	CcSEcCtD
Diflunisal—Renal failure—Doxorubicin—bone cancer	0.000255	0.00497	CcSEcCtD
Diflunisal—Erythema multiforme—Methotrexate—bone cancer	0.000254	0.00495	CcSEcCtD
Diflunisal—Jaundice—Doxorubicin—bone cancer	0.000253	0.00492	CcSEcCtD
Diflunisal—Stomatitis—Doxorubicin—bone cancer	0.000253	0.00492	CcSEcCtD
Diflunisal—Hepatitis—Epirubicin—bone cancer	0.000252	0.0049	CcSEcCtD
Diflunisal—Tinnitus—Methotrexate—bone cancer	0.000251	0.00488	CcSEcCtD
Diflunisal—Asthenia—Cisplatin—bone cancer	0.00025	0.00486	CcSEcCtD
Diflunisal—Sweating—Doxorubicin—bone cancer	0.000249	0.00484	CcSEcCtD
Diflunisal—Haematuria—Doxorubicin—bone cancer	0.000247	0.00482	CcSEcCtD
Diflunisal—Visual impairment—Epirubicin—bone cancer	0.000243	0.00472	CcSEcCtD
Diflunisal—Agranulocytosis—Doxorubicin—bone cancer	0.000242	0.00471	CcSEcCtD
Diflunisal—Diarrhoea—Cisplatin—bone cancer	0.000238	0.00464	CcSEcCtD
Diflunisal—Erythema multiforme—Epirubicin—bone cancer	0.000238	0.00463	CcSEcCtD
Diflunisal—Tinnitus—Epirubicin—bone cancer	0.000235	0.00457	CcSEcCtD
Diflunisal—Flushing—Epirubicin—bone cancer	0.000234	0.00455	CcSEcCtD
Diflunisal—Hepatitis—Doxorubicin—bone cancer	0.000233	0.00454	CcSEcCtD
Diflunisal—Visual impairment—Doxorubicin—bone cancer	0.000224	0.00437	CcSEcCtD
Diflunisal—Vomiting—Cisplatin—bone cancer	0.000221	0.00431	CcSEcCtD
Diflunisal—Vision blurred—Methotrexate—bone cancer	0.000221	0.0043	CcSEcCtD
Diflunisal—Erythema multiforme—Doxorubicin—bone cancer	0.00022	0.00429	CcSEcCtD
Diflunisal—Rash—Cisplatin—bone cancer	0.00022	0.00428	CcSEcCtD
Diflunisal—PTGS1—connective tissue—bone cancer	0.00022	0.0219	CbGeAlD
Diflunisal—Dermatitis—Cisplatin—bone cancer	0.000219	0.00427	CcSEcCtD
Diflunisal—Tinnitus—Doxorubicin—bone cancer	0.000217	0.00423	CcSEcCtD
Diflunisal—Flushing—Doxorubicin—bone cancer	0.000216	0.00421	CcSEcCtD
Diflunisal—Flatulence—Epirubicin—bone cancer	0.000216	0.0042	CcSEcCtD
Diflunisal—Tension—Epirubicin—bone cancer	0.000215	0.00419	CcSEcCtD
Diflunisal—Nervousness—Epirubicin—bone cancer	0.000213	0.00414	CcSEcCtD
Diflunisal—Muscle spasms—Epirubicin—bone cancer	0.000211	0.0041	CcSEcCtD
Diflunisal—Vertigo—Methotrexate—bone cancer	0.00021	0.0041	CcSEcCtD
Diflunisal—PTGS2—connective tissue—bone cancer	0.00021	0.0209	CbGeAlD
Diflunisal—Nausea—Cisplatin—bone cancer	0.000207	0.00403	CcSEcCtD
Diflunisal—Vision blurred—Epirubicin—bone cancer	0.000207	0.00402	CcSEcCtD
Diflunisal—Flatulence—Doxorubicin—bone cancer	0.0002	0.00389	CcSEcCtD
Diflunisal—Chest pain—Methotrexate—bone cancer	0.000199	0.00388	CcSEcCtD
Diflunisal—Tension—Doxorubicin—bone cancer	0.000199	0.00387	CcSEcCtD
Diflunisal—Nervousness—Doxorubicin—bone cancer	0.000197	0.00383	CcSEcCtD
Diflunisal—Vertigo—Epirubicin—bone cancer	0.000197	0.00383	CcSEcCtD
Diflunisal—Syncope—Epirubicin—bone cancer	0.000197	0.00383	CcSEcCtD
Diflunisal—Muscle spasms—Doxorubicin—bone cancer	0.000195	0.0038	CcSEcCtD
Diflunisal—Palpitations—Epirubicin—bone cancer	0.000194	0.00377	CcSEcCtD
Diflunisal—Confusional state—Methotrexate—bone cancer	0.000193	0.00375	CcSEcCtD
Diflunisal—Loss of consciousness—Epirubicin—bone cancer	0.000193	0.00375	CcSEcCtD
Diflunisal—Anaphylactic shock—Methotrexate—bone cancer	0.000191	0.00372	CcSEcCtD
Diflunisal—Vision blurred—Doxorubicin—bone cancer	0.000191	0.00372	CcSEcCtD
Diflunisal—Thrombocytopenia—Methotrexate—bone cancer	0.000187	0.00364	CcSEcCtD
Diflunisal—Chest pain—Epirubicin—bone cancer	0.000187	0.00363	CcSEcCtD
Diflunisal—Hyperhidrosis—Methotrexate—bone cancer	0.000185	0.0036	CcSEcCtD
Diflunisal—Vertigo—Doxorubicin—bone cancer	0.000182	0.00355	CcSEcCtD
Diflunisal—Anorexia—Methotrexate—bone cancer	0.000182	0.00355	CcSEcCtD
Diflunisal—Syncope—Doxorubicin—bone cancer	0.000182	0.00354	CcSEcCtD
Diflunisal—Confusional state—Epirubicin—bone cancer	0.00018	0.00351	CcSEcCtD
Diflunisal—Palpitations—Doxorubicin—bone cancer	0.000179	0.00349	CcSEcCtD
Diflunisal—Anaphylactic shock—Epirubicin—bone cancer	0.000179	0.00348	CcSEcCtD
Diflunisal—Oedema—Epirubicin—bone cancer	0.000179	0.00348	CcSEcCtD
Diflunisal—Loss of consciousness—Doxorubicin—bone cancer	0.000178	0.00347	CcSEcCtD
Diflunisal—Shock—Epirubicin—bone cancer	0.000176	0.00343	CcSEcCtD
Diflunisal—Thrombocytopenia—Epirubicin—bone cancer	0.000175	0.00341	CcSEcCtD
Diflunisal—Hyperhidrosis—Epirubicin—bone cancer	0.000173	0.00337	CcSEcCtD
Diflunisal—Insomnia—Methotrexate—bone cancer	0.000173	0.00337	CcSEcCtD
Diflunisal—Chest pain—Doxorubicin—bone cancer	0.000173	0.00336	CcSEcCtD
Diflunisal—Paraesthesia—Methotrexate—bone cancer	0.000172	0.00334	CcSEcCtD
Diflunisal—Anorexia—Epirubicin—bone cancer	0.00017	0.00332	CcSEcCtD
Diflunisal—Dyspnoea—Methotrexate—bone cancer	0.00017	0.00332	CcSEcCtD
Diflunisal—Somnolence—Methotrexate—bone cancer	0.00017	0.00331	CcSEcCtD
Diflunisal—Dyspepsia—Methotrexate—bone cancer	0.000168	0.00328	CcSEcCtD
Diflunisal—Confusional state—Doxorubicin—bone cancer	0.000167	0.00325	CcSEcCtD
Diflunisal—Decreased appetite—Methotrexate—bone cancer	0.000166	0.00323	CcSEcCtD
Diflunisal—Oedema—Doxorubicin—bone cancer	0.000165	0.00322	CcSEcCtD
Diflunisal—Anaphylactic shock—Doxorubicin—bone cancer	0.000165	0.00322	CcSEcCtD
Diflunisal—Fatigue—Methotrexate—bone cancer	0.000165	0.00321	CcSEcCtD
Diflunisal—Shock—Doxorubicin—bone cancer	0.000163	0.00317	CcSEcCtD
Diflunisal—Thrombocytopenia—Doxorubicin—bone cancer	0.000162	0.00315	CcSEcCtD
Diflunisal—Insomnia—Epirubicin—bone cancer	0.000162	0.00315	CcSEcCtD
Diflunisal—Paraesthesia—Epirubicin—bone cancer	0.000161	0.00313	CcSEcCtD
Diflunisal—Hyperhidrosis—Doxorubicin—bone cancer	0.00016	0.00311	CcSEcCtD
Diflunisal—Dyspnoea—Epirubicin—bone cancer	0.000159	0.0031	CcSEcCtD
Diflunisal—Somnolence—Epirubicin—bone cancer	0.000159	0.0031	CcSEcCtD
Diflunisal—Anorexia—Doxorubicin—bone cancer	0.000158	0.00307	CcSEcCtD
Diflunisal—Feeling abnormal—Methotrexate—bone cancer	0.000157	0.00307	CcSEcCtD
Diflunisal—Dyspepsia—Epirubicin—bone cancer	0.000157	0.00307	CcSEcCtD
Diflunisal—Gastrointestinal pain—Methotrexate—bone cancer	0.000156	0.00304	CcSEcCtD
Diflunisal—Decreased appetite—Epirubicin—bone cancer	0.000155	0.00303	CcSEcCtD
Diflunisal—Fatigue—Epirubicin—bone cancer	0.000154	0.003	CcSEcCtD
Diflunisal—Constipation—Epirubicin—bone cancer	0.000153	0.00298	CcSEcCtD
Diflunisal—Urticaria—Methotrexate—bone cancer	0.000152	0.00296	CcSEcCtD
Diflunisal—Body temperature increased—Methotrexate—bone cancer	0.000151	0.00294	CcSEcCtD
Diflunisal—PTGS1—tendon—bone cancer	0.000151	0.0151	CbGeAlD
Diflunisal—Insomnia—Doxorubicin—bone cancer	0.00015	0.00291	CcSEcCtD
Diflunisal—Paraesthesia—Doxorubicin—bone cancer	0.000149	0.00289	CcSEcCtD
Diflunisal—Dyspnoea—Doxorubicin—bone cancer	0.000148	0.00287	CcSEcCtD
Diflunisal—Feeling abnormal—Epirubicin—bone cancer	0.000147	0.00287	CcSEcCtD
Diflunisal—Somnolence—Doxorubicin—bone cancer	0.000147	0.00286	CcSEcCtD
Diflunisal—Gastrointestinal pain—Epirubicin—bone cancer	0.000146	0.00285	CcSEcCtD
Diflunisal—Dyspepsia—Doxorubicin—bone cancer	0.000146	0.00284	CcSEcCtD
Diflunisal—PTGS1—spinal cord—bone cancer	0.000146	0.0145	CbGeAlD
Diflunisal—PTGS2—tendon—bone cancer	0.000144	0.0144	CbGeAlD
Diflunisal—Decreased appetite—Doxorubicin—bone cancer	0.000144	0.0028	CcSEcCtD
Diflunisal—Fatigue—Doxorubicin—bone cancer	0.000143	0.00278	CcSEcCtD
Diflunisal—Urticaria—Epirubicin—bone cancer	0.000142	0.00277	CcSEcCtD
Diflunisal—Constipation—Doxorubicin—bone cancer	0.000142	0.00276	CcSEcCtD
Diflunisal—Body temperature increased—Epirubicin—bone cancer	0.000141	0.00275	CcSEcCtD
Diflunisal—Hypersensitivity—Methotrexate—bone cancer	0.000141	0.00274	CcSEcCtD
Diflunisal—PTGS2—bone marrow—bone cancer	0.00014	0.0139	CbGeAlD
Diflunisal—PTGS2—spinal cord—bone cancer	0.000139	0.0139	CbGeAlD
Diflunisal—Asthenia—Methotrexate—bone cancer	0.000137	0.00267	CcSEcCtD
Diflunisal—Feeling abnormal—Doxorubicin—bone cancer	0.000136	0.00266	CcSEcCtD
Diflunisal—Gastrointestinal pain—Doxorubicin—bone cancer	0.000135	0.00263	CcSEcCtD
Diflunisal—Pruritus—Methotrexate—bone cancer	0.000135	0.00263	CcSEcCtD
Diflunisal—Hypersensitivity—Epirubicin—bone cancer	0.000132	0.00257	CcSEcCtD
Diflunisal—Urticaria—Doxorubicin—bone cancer	0.000131	0.00256	CcSEcCtD
Diflunisal—Body temperature increased—Doxorubicin—bone cancer	0.000131	0.00255	CcSEcCtD
Diflunisal—Diarrhoea—Methotrexate—bone cancer	0.000131	0.00255	CcSEcCtD
Diflunisal—Asthenia—Epirubicin—bone cancer	0.000128	0.0025	CcSEcCtD
Diflunisal—Pruritus—Epirubicin—bone cancer	0.000127	0.00246	CcSEcCtD
Diflunisal—Dizziness—Methotrexate—bone cancer	0.000126	0.00246	CcSEcCtD
Diflunisal—Diarrhoea—Epirubicin—bone cancer	0.000122	0.00238	CcSEcCtD
Diflunisal—Hypersensitivity—Doxorubicin—bone cancer	0.000122	0.00237	CcSEcCtD
Diflunisal—Vomiting—Methotrexate—bone cancer	0.000122	0.00237	CcSEcCtD
Diflunisal—Rash—Methotrexate—bone cancer	0.000121	0.00235	CcSEcCtD
Diflunisal—Dermatitis—Methotrexate—bone cancer	0.00012	0.00234	CcSEcCtD
Diflunisal—Headache—Methotrexate—bone cancer	0.00012	0.00233	CcSEcCtD
Diflunisal—Asthenia—Doxorubicin—bone cancer	0.000119	0.00231	CcSEcCtD
Diflunisal—Dizziness—Epirubicin—bone cancer	0.000118	0.0023	CcSEcCtD
Diflunisal—Pruritus—Doxorubicin—bone cancer	0.000117	0.00228	CcSEcCtD
Diflunisal—Vomiting—Epirubicin—bone cancer	0.000114	0.00221	CcSEcCtD
Diflunisal—Nausea—Methotrexate—bone cancer	0.000114	0.00221	CcSEcCtD
Diflunisal—Diarrhoea—Doxorubicin—bone cancer	0.000113	0.0022	CcSEcCtD
Diflunisal—Rash—Epirubicin—bone cancer	0.000113	0.0022	CcSEcCtD
Diflunisal—Dermatitis—Epirubicin—bone cancer	0.000113	0.00219	CcSEcCtD
Diflunisal—Headache—Epirubicin—bone cancer	0.000112	0.00218	CcSEcCtD
Diflunisal—Dizziness—Doxorubicin—bone cancer	0.000109	0.00213	CcSEcCtD
Diflunisal—Nausea—Epirubicin—bone cancer	0.000106	0.00207	CcSEcCtD
Diflunisal—Vomiting—Doxorubicin—bone cancer	0.000105	0.00205	CcSEcCtD
Diflunisal—Rash—Doxorubicin—bone cancer	0.000104	0.00203	CcSEcCtD
Diflunisal—Dermatitis—Doxorubicin—bone cancer	0.000104	0.00203	CcSEcCtD
Diflunisal—Headache—Doxorubicin—bone cancer	0.000104	0.00202	CcSEcCtD
Diflunisal—Nausea—Doxorubicin—bone cancer	9.83e-05	0.00191	CcSEcCtD
